Characterization of arginase expression in glioma-associated microglia and macrophages

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Zhang, Ian ^a   Alizadeh, Darya ^a   Liang, Junling ^b   Zhang, Leying ^a   Gao, Hang ^c   Song, Yanyan ^d   Ren, Hui ^d   Ouyang, Mao ^e   Wu, Xiwei ^a   D'Apuzzo, Massimo ^a   Badie, Behnam ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; ARG1 PROTEIN, MOUSE; ARGINASE; LY ANTIGEN; LY6G ANTIGEN, MOUSE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE MIGRATION; MICROARRAY ANALYSIS; MICROGLIA; MOUSE; NEUTROPHIL; NONHUMAN; POLARIZATION; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANIMAL; ANTIBODY SPECIFICITY; BRAIN TUMOR; C57BL MOUSE; CANCER TRANSPLANTATION; GENETICS; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TIME FACTOR; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, LY; ARGINASE; BRAIN NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; ORGAN SPECIFICITY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR MICROENVIRONMENT;

EID: 85005943308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165118     Document Type: Article

References (25)

1. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, et al. Macrophage polarization in tumour progression. Semin Cancer Biol. 2008; 18:349-55. doi: 10.1016/j.semcancer.2008.03.004 PMID: 18467122
2. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012; 12:253-68. doi: 10.1038/nri3175 PMID: 22437938
3. Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer J. 2010; 16:348-53. doi: 10.1097/PPO.0b013e3181eb3358 PMID: 20693846
4. Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol. 2012; 14:1379-92. doi: 10.1093/neuonc/nos158 PMID: 22965162
5. Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol. 2012; 189:444-53. doi: 10.4049/jimmunol.1103248 PMID: 22664874
6. Umemura N, Saio M, Suwa T, Kitoh Y, Bai J, Nonaka K, et al. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol. 2008; 83:1136-44. doi: 10.1189/jlb.0907611 PMID: 18285406
7. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006; 42:717-27. doi: 10.1016/j.ejca.2006.01.003 PMID: 16520032
8. Markovic DS, Vinnakota K, Chirasani S, Synowitz M, Raguet H, Stock K, et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci U S A. 2009; 106:12530-5. doi: 10.1073/pnas.0804273106 PMID: 19617536
9. Li W, Graeber MB. The molecular profile of microglia under the influence of glioma. Neuro Oncol. 2012; 14:958-78. doi: 10.1093/neuonc/nos116 PMID: 22573310
10. Gabrusiewicz K, Ellert-Miklaszewska A, Lipko M, Sielska M, Frankowska M, Kaminska B. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One. 2011; 6:e23902. doi: 10.1371/journal.pone.0023902 PMID: 21901144
11. Badie B, Schartner JM. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery. 2000; 46:957-61; discussion 61-2. PMID: 10764271
12. Alizadeh D, Zhang L, Brown CE, Farrukh O, Jensen MC, Badie B. Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy. Clin Cancer Res. 2010; 16:3399-408. doi: 10.1158/1078-0432.CCR-09-3087 PMID: 20570924
13. Terada K, Wakimoto H, Tyminski E, Chiocca EA, Saeki Y. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Gene Ther. 2006; 13:705-14. doi: 10.1038/sj.gt.3302717 PMID: 16421599
14. Chen X, Zhang L, Zhang IY, Liang J, Wang H, Ouyang M, et al. RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Res. 2014; 74:7285-97. doi: 10.1158/0008-5472.CAN-14-1240 PMID: 25326491
15. Wang H, Zhang L, Zhang IY, Chen X, Da Fonseca A, Wu S, et al. S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages. Clin Cancer Res. 2013; 19:3764-75. doi: 10.1158/1078-0432.CCR-12-3725 PMID: 23719262
16. Tripathi P. Nitric oxide and immune response. Indian journal of biochemistry & biophysics. 2007; 44:310-9.
17. Krause MS, McClenaghan NH, Flatt PR, de Bittencourt PI, Murphy C, Newsholme P. L-arginine is essential for pancreatic beta-cell functional integrity, metabolism and defense from inflammatory challenge. J Endocrinol. 2011; 211:87-97. doi: 10.1530/JOE-11-0236 PMID: 21784771
18. Galarneau H, Villeneuve J, Gowing G, Julien JP, Vallieres L. Increased glioma growth in mice depleted of macrophages. Cancer Res. 2007; 67:8874-81. doi: 10.1158/0008-5472.CAN-07-0177 PMID: 17875729
19. Kushchayev SV, Kushchayeva YS, Wiener PC, Scheck AC, Badie B, Preul MC. Monocyte-derived cells of the brain and malignant gliomas: the double face of Janus. World Neurosurg. 2014; 82:1171-86. doi: 10.1016/j.wneu.2012.11.059 PMID: 23178919
20. Sarkar S, Doring A, Zemp FJ, Silva C, Lun X, Wang X, et al. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Nat Neurosci. 2014; 17:46-55. doi: 10.1038/nn. 3597 PMID: 24316889
21. Kohanbash G, McKaveney K, Sakaki M, Ueda R, Mintz AH, Amankulor N, et al. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-alpha. Cancer Res. 2013; 73:6413-23. doi: 10.1158/0008-5472.CAN-12-4124 PMID: 24030977
22. Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA. Hypoxia and tumor-associated macrophages: A deadly alliance in support of tumor progression. Oncoimmunology. 2014; 3:e27561. doi: 10.4161/onci.27561 PMID: 24744977
23. Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, et al. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol Med. 2012; 18:519-27. doi: 10.2119/molmed.2011.00217 PMID: 22294205
24. Sippel TR, White J, Nag K, Tsvankin V, Klaassen M, Kleinschmidt-DeMasters BK, et al. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res. 2011; 17:6992-7002. doi: 10.1158/1078-0432.CCR-11-1107 PMID: 21948231
25. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol. 2011; 89:557-63. doi: 10.1189/jlb.0710409 PMID: 21248152